Cash Flow Statement

Amortizatization of Intangibles Amortizatization of Intangibles Capital Expenditures Capital Expenditures Cash from Financing Activities Cash from Financing Activities Cash from Investing Activities Cash from Investing Activities Cash from Operations Cash from Operations Change in Account Payables Change in Account Payables Change in Accured Expenses Change in Accured Expenses Change in Acquisitions & Divestments Change in Acquisitions & Divestments Change in Cash Change in Inventory Change in Inventory Change in Receivables Change in Receivables Depreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and Depletion Depreciation and Depletion Free Cash Flow Free Cash Flow Gains from Investment Securities Gains from Investment Securities Net Cash Flow Net Cash Flow Net Income Other Working Capital Changes Other Working Capital Changes Other financing activities Other financing activities Share-based Compensation Share-based Compensation Shares Issued

Daily Values

Growth Metrics

Others

Ratios

Astera Labs (ALAB) Asset Writedowns and Impairment (2023 - 2024)

Astera Labs' Asset Writedowns and Impairment history spans 2 years, with the latest figure at -$783000.0 for Q4 2024.

For the quarter ending Q4 2024, Asset Writedowns and Impairment fell 557.89% year-over-year to -$783000.0, compared with a TTM value of $168000.0 through Dec 2024, down 98.38%, and an annual FY2024 reading of $168000.0, down 98.38% over the prior year.
Asset Writedowns and Impairment for Q4 2024 was -$783000.0 at Astera Labs, down from -$542000.0 in the prior quarter.
The five-year high for Asset Writedowns and Impairment was $9.7 million in Q1 2023, with the low at -$783000.0 in Q4 2024.